title: Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians.
abstract: Venous thromboembolism is a common condition affecting 7.1 persons per 10,000 person-years among community residents. Incidence rates for venous thromboembolism are higher in men and African Americans and increase substantially with age. It is critical to treat deep venous thrombosis at an early stage to avoid development of further complications, such as pulmonary embolism or recurrent deep venous thrombosis. The target audience for this guideline is all clinicians caring for patients who have been given a diagnosis of deep venous thrombosis or pulmonary embolism. The target patient population is patients receiving a diagnosis of pulmonary embolism or lower-extremity deep venous thrombosis.
authors.affiliation: American College of Physicians, Philadelphia, Pennsylvania 19106, USA.
authors.forename: Vincenza
authors.initials: V
authors.lastname: Snow
authors.forename: Amir
authors.initials: A
authors.lastname: Qaseem
authors.forename: Patricia
authors.initials: P
authors.lastname: Barry
authors.forename: E Rodney
authors.initials: ER
authors.lastname: Hornbake
authors.forename: Jonathan E
authors.initials: JE
authors.lastname: Rodnick
authors.forename: Timothy
authors.initials: T
authors.lastname: Tobolic
authors.forename: Belinda
authors.initials: B
authors.lastname: Ireland
authors.forename: Jodi B
authors.initials: JB
authors.lastname: Segal
authors.forename: Eric B
authors.initials: EB
authors.lastname: Bass
authors.forename: Kevin B
authors.initials: KB
authors.lastname: Weiss
authors.forename: Lee
authors.initials: L
authors.lastname: Green
authors.forename: Douglas K
authors.initials: DK
authors.lastname: Owens
mesh_terms: D000553:Ambulatory Care; D000925:Anticoagulants / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D005260:Female; D006493:Heparin / Q000191:economics / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000191:economics / Q000627:therapeutic use; D006801:Humans; D019934:International Normalized Ratio; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000517:prevention & control / Q000628:therapy; D011655:Pulmonary Embolism / Q000150:complications / Q000517:prevention & control / Q000628:therapy; D055502:Secondary Prevention; D053828:Stockings, Compression; D013923:Thromboembolism / Q000150:complications / Q000517:prevention & control / Q000628:therapy*; D015912:Thrombolytic Therapy; D016306:Vena Cava Filters; D020246:Venous Thrombosis / Q000150:complications / Q000517:prevention & control / Q000628:therapy*; D014812:Vitamin K / Q000037:antagonists & inhibitors
chemical_list: D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D014812:Vitamin K; D006493:Heparin